Syra Health Corp. Class A (SYRA)
OTHER OTC:SYRA
SYRA Stock Chart & Stats
$0.09
-$0.12(-16.06%)
At close: 4:00 PM EST
$0.09
-$0.12(-16.06%)
Day’s Range― - ―
52-Week Range$0.03 - $0.31
Previous CloseN/A
Volume2.20M
Average Volume (3M)9.76K
Market Cap
$3.20M
Enterprise Value$1.57M
Total Cash (Recent Filing)$1.61M
Total Debt (Recent Filing)$143.79K
Price to Earnings (P/E)―
Beta0.83
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding11,339,169
10 Day Avg. Volume11,249
30 Day Avg. Volume9,759
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.49
Price to Sales (P/S)0.14
P/FCF Ratio-2.28
Enterprise Value/Market Cap0.49
Enterprise Value/Revenue0.22
Enterprise Value/Gross Profit0.73
Enterprise Value/Ebitda-1.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Margin ImprovementMaterial gross-margin expansion and a much smaller net loss in 2025 show improving unit economics. Sustained margin recovery reduces the revenue needed to reach breakeven, improves resilience to contract pricing pressure, and creates a clearer path to durable profitability if maintained.
Reduced Cash BurnA dramatic decline in operating cash burn reflects stronger cash discipline and working-capital management. If sustained, lower negative cash flow extends runway, reduces near-term financing needs, and allows management to allocate resources to core program delivery and scaling profitable contracts.
Low LeverageVery low debt and sharply lower total borrowings provide financial flexibility for a services firm with lumpy government receipts. Limited leverage reduces interest expense risk, preserves covenant headroom, and supports investment in operations without excessive default or refinancing pressure.
Bears Say
Ongoing UnprofitabilityDespite improvements, persistent net losses and negative operating cash flow mean the business still relies on external capital to fund operations. This elevates dilution and refinancing risk over the medium term, and limits the company's ability to self-fund growth or absorb contract delays.
Revenue VolatilityTop-line inconsistency — a modest revenue decline in 2025 after multi-year scale-up — undermines operating leverage for a services business. For government contracting, revenue volatility complicates capacity planning and margin conversion, increasing the risk that fixed costs pressure profitability.
Eroding EquityDeclining shareholders' equity and negative ROE indicate capital erosion from repeated losses. A shrinking equity base weakens the balance sheet buffer against contract setbacks, raises the likelihood of future equity raises, and constrains long-term ability to invest without further dilution.
Syra Health Corp. Class A News
SYRA FAQ
What was Syra Health Corp. Class A’s price range in the past 12 months?
Syra Health Corp. Class A lowest stock price was $0.03 and its highest was $0.31 in the past 12 months.
What is Syra Health Corp. Class A’s market cap?
Syra Health Corp. Class A’s market cap is $3.20M.
When is Syra Health Corp. Class A’s upcoming earnings report date?
Syra Health Corp. Class A’s upcoming earnings report date is May 07, 2026 which is in 28 days.
How were Syra Health Corp. Class A’s earnings last quarter?
Syra Health Corp. Class A released its earnings results on Mar 12, 2026. The company reported -$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.011.
Is Syra Health Corp. Class A overvalued?
According to Wall Street analysts Syra Health Corp. Class A’s price is currently Overvalued.
Does Syra Health Corp. Class A pay dividends?
Syra Health Corp. Class A does not currently pay dividends.
What is Syra Health Corp. Class A’s EPS estimate?
Syra Health Corp. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syra Health Corp. Class A have?
Syra Health Corp. Class A has 11,339,169 shares outstanding.
What happened to Syra Health Corp. Class A’s price movement after its last earnings report?
Syra Health Corp. Class A reported an EPS of -$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5%.
Which hedge fund is a major shareholder of Syra Health Corp. Class A?
Currently, no hedge funds are holding shares in SYRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Syra Health Corp. Class A
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
―
Cryo-Cell International
―
P3 Health Partners
―
Ownership Overview
Options Prices
Currently, No data available
---